Kozak & Associates’s Boston Scientific BSX Stock Holding History

Kozak & Associates’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46K	Hold	1,068	–	–	0.01%	151
2026 Q1	$67.5K	Hold	1,068	–	–	0.01%	127
2025 Q4	$104K	Sell	1,068 -2,136	-67%	-$209K	0.02%	106
2025 Q3	$326K	Hold	3,204	–	–	0.06%	63
2025 Q2	$330K	Hold	3,204	–	–	0.07%	58
2025 Q1	$302K	Hold	3,204	–	–	0.08%	53
2024 Q4	$291K	Hold	3,204	–	–	0.07%	60
2024 Q3	$279K	Hold	3,204	–	–	0.07%	65
2024 Q2	$244K	Hold	3,204	–	–	0.06%	69
2024 Q1	$239K	Hold	3,204	–	–	0.06%	73
2023 Q4	$193K	Hold	3,204	–	–	0.06%	76
2023 Q3	$167K	Hold	3,204	–	–	0.06%	86
2023 Q2	$172K	Hold	3,204	–	–	0.07%	88
2023 Q1	$160K	Hold	3,204	–	–	0.07%	92
2022 Q4	$148K	Hold	3,204	–	–	0.07%	92
2022 Q3	$127K	Hold	3,204	–	–	0.08%	91
2022 Q2	$119K	Hold	3,204	–	–	0.08%	97
2022 Q1	$134K	Hold	3,204	–	–	0.09%	97
2021 Q4	$134K	Hold	3,204	–	–	0.09%	97
2021 Q3	$132K	Buy	+3,204	New	+$142K	0.08%	97

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kozak & Associates's BSX Position: Q2 2026 in Review

Kozak & Associates held its Boston Scientific (BSX) position steady in Q2 2026 at 1,068 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #151.

Kozak & Associates first reported a position in BSX in Q3 2021 and has held it in 20 quarters since. The position peaked at $330K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Kozak & Associates held 1,068 shares of Boston Scientific worth $46K as of Q2 2026.
Kozak & Associates left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.01% of Kozak & Associates's portfolio in Q2 2026, its #151 holding.
Kozak & Associates first reported a position in Boston Scientific in Q3 2021 and has held it in 20 quarters since.
Kozak & Associates's Boston Scientific position peaked at $330K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.